00855nam0-22002771i-450 99000411387040332120230706111714.0000411387FED01000411387(Aleph)000411387FED0100041138719990530d1962----km-y0itay50------bafrey-------00-y-Histoire et mystèrepar Jean Lacroix[s.l.]Castermanc1962134 p.21 cmCahiers de l'Actualité Religieusecollection dirigée par le College Dominicain de Theologie a La Sarte- Huy18Lacroix,Jean<1900-1986>53449ITUNINARICAUNIMARCBK990004113870403321FIL.TEOR.1663IST.FIL.T.1359FLFBCFLFBCHistoire et mystère477993UNINA01709nam 2200349 n 450 991068849010332120250808225323.0(CKB)5400000000045416(NjHacI)995400000000045416(EXLCZ)99540000000004541620230626d2020 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDrug Repurposing Hypothesis, Molecular Aspects and Therapeutic Applications /edited by Farid A. BadriaLondon, England :IntechOpen,2020.1 online resource (234 pages)1-83968-522-0 Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.Drug RepurposingDrug developmentDrug development.615.19Badria Farid A.NjHacINjHaclBOOK9910688490103321Drug Repurposing2954022UNINA